What is Zymeworks's R&D?

Zymeworks (ZYME) reported R&D of $34.46M in Q1 2026.

How has Zymeworks's R&D changed year-over-year?

Zymeworks's R&D decreased by 3.6% year-over-year, from $35.74M to $34.46M.

What is the long-term trend for Zymeworks's R&D?

Over 2 years (2022 to 2024), Zymeworks's R&D has grown at a -19.7% compound annual growth rate (CAGR), from $208.6M to $134.62M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Zymeworks ZYME R&D

R&D at other companies

AmgenAMGN

$1.72B+15.7%

AnaptysBio, Inc.ANAB

$33.99M-17.5%

Viridian Therapeutics, Inc.VRDN

$77.63M+1.0%

AbCellera Biologics Inc.ABCL

$46.66M+9.8%

Stoke Therapeutics, Inc.STOK

$39.67M+21.4%

Nurix Therapeutics, Inc.NRIX

$84.14M+20.8%

Segments

By product

See full

Expense for other preclinical and research programs$6.37M+226%

Zanidatamab$4.62M-58.7%

ZW191$2.85M-2.7%

ZW220$2.14M+439%

ZW251$2.03M+1,085%

ZW171$1.83M-31.5%

By segment

See full

Reportable Segment$34.46M-3.6%

Other financials

Income statement

See full

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

See full

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

See full

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

See full

Market cap$1.76B+125%

Enterprise value$1.53B+112%

P/S21.6×+13.2×

Profitability

See full

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

See full

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zymeworks's R&D?: Zymeworks (ZYME) reported R&D of $34.46M in Q1 2026.
How has Zymeworks's R&D changed year-over-year?: Zymeworks's R&D decreased by 3.6% year-over-year, from $35.74M to $34.46M.
What is the long-term trend for Zymeworks's R&D?: Over 2 years (2022 to 2024), Zymeworks's R&D has grown at a -19.7% compound annual growth rate (CAGR), from $208.6M to $134.62M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.